Proteomic changes at 8 weeks after infection are associated with chronic liver pathology in experimental schistosomiasis

被引:10
作者
Manivannan, Bhagyashree [1 ,2 ]
Jordan, T. William [1 ,2 ]
Secor, W. Evan [3 ]
La Flamme, Anne Camille [1 ,2 ]
机构
[1] Victoria Univ Wellington, Sch Biol Sci, Wellington 6140, New Zealand
[2] Victoria Univ Wellington, Ctr Biodiscovery, Wellington 6140, New Zealand
[3] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA 30340 USA
关键词
Schistosomiasis; Hepatosplenic; Liver fibrosis; 2D-DIGE; Proteomics; MALDI-TOF/TOF; PROTEIN EXPRESSION; MANSONI INFECTIONS; MICE;
D O I
10.1016/j.jprot.2011.12.025
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Chronic Schistosoma mansoni infection can present as a moderate or severe disease, termed intestinal or hepatosplenic schistosomiasis, respectively. Similarly, either moderate splenomegaly or hypersplenomegaly syndrome develops in CBA/J mice by 20 weeks of infection and is similar to intestinal or hepatosplenic schistosomiasis respectively. Using this mouse model and two-dimensional differential in gel electrophoresis, the liver proteomic signatures of uninfected mice and mice infected for 6, 8, 12, or 20 weeks were compared, and significant protein spots identified using mass spectrometry. We found the greatest number of changes at 12 weeks suggesting that this period represents the peak time of change. Pathway analysis identified specific proteins and pathways that correlated to the pathological changes indicative of severe disease, and these pathways were involved as early as 8 weeks after infection. These findings provide insight into the development of severe liver pathology in schistosomiasis and may aid in developing biomarkers for hepatosplenic schistosomiasis. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:1838 / 1848
页数:11
相关论文
共 18 条
[1]   Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia [J].
Anensen, Nina ;
Haaland, Ingvild ;
D'Santos, Clive ;
Van Belle, Werner ;
Gjertsen, Bjorn Tore .
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2006, 7 (03) :199-207
[2]   Metabonomic investigation of human Schistosoma mansoni infection [J].
Balog, Crina I. A. ;
Meissner, Axel ;
Goraler, Sibel ;
Bladergroen, Marco R. ;
Vennervald, Birgitte J. ;
Mayboroda, Oleg A. ;
Deelder, Andre M. .
MOLECULAR BIOSYSTEMS, 2011, 7 (05) :1473-1480
[3]   Profiling the metabolic proteome of bovine mammary tissue [J].
Beddek, Amanda J. ;
Rawson, Pisana ;
Peng, Lifeng ;
Snell, Russell ;
Lehnert, Klaus ;
Ward, Hamish E. ;
Jordan, T. William .
PROTEOMICS, 2008, 8 (07) :1502-1515
[4]   How much human helminthiasis is there in the world? [J].
Crompton, DWT .
JOURNAL OF PARASITOLOGY, 1999, 85 (03) :397-403
[5]   Immunopathogenesis and immunoregulation in schistosomiasis - Distinct chronic pathologic syndromes in CBA/J mice [J].
Freeman, GL ;
Montesano, MA ;
Secor, WE ;
Colley, DG ;
Howard, MJ ;
Bosshardt, SC .
MICROBIAL PATHOGENESIS AND IMMUNE RESPONSE II, 1996, 797 :151-165
[6]  
GEHealthcare, 2005, DECYDER 2D SOFTW VER
[7]   Myc proteins as therapeutic targets [J].
Gustafson, W. C. ;
Weiss, W. A. .
ONCOGENE, 2010, 29 (09) :1249-1259
[8]   Differential liver protein expression during schistosomiasis [J].
Harvie, Marina ;
Jordan, Thomas William ;
La Flamme, Anne Camille .
INFECTION AND IMMUNITY, 2007, 75 (02) :736-744
[9]  
HENDERSON GS, 1993, AM J PATHOL, V142, P703
[10]   AP-1 function and regulation [J].
Karin, M ;
Liu, ZG ;
Zandi, E .
CURRENT OPINION IN CELL BIOLOGY, 1997, 9 (02) :240-246